(1)
Celik, A.; Berg, T.; Gibson, M.; Jensen, M.-B.; Kümler, I.; Eßer-Naumann, S.; Jakobsen, E. H.; Knoop, A.; Nielsen, D. Capecitabine Monotherapy As First-Line Treatment in Advanced HER2-Normal Breast Cancer – a Nationwide, Retrospective Study. AO 2024, 63, 494-502.